Preventing European cancer epidemic 

Europe will face a cancer epidemic in the next decade if weaknesses in cancer health systems and cancer research are not urgently addressed, say the authors of a major new report. The large-scale collaborative research project, in which the University is a key participant, warns that prioritising cancer research is crucial for European countries to deliver more affordable, higher quality, and more equitable cancer care. With an estimated one million cancer diagnoses missed across Europe in the last two years, the impact of the COVID-19 pandemic is predicted to set back European cancer outcomes by almost a decade, it states. Commissioned by The Lancet Oncology, the report, which is titled European Groundshot—addressing Europe's cancer research challenges, highlights the pivotal importance of cancer research in tackling the unprecedented challenges facing European cancer systems and makes key recommendations for how this can be achieved. We must work towards a more equitable agenda where all citizens and patients, no matter where they live, will benefit equally from advances in cancer research. Professor Peter Selby CBE The report brings together a wide range of patient, scientific, and health-care experts with detailed knowledge of cancer research activity across Europe. Peter Selby CBE, Professor of Cancer Medicine in the School of Medicine , is one of the authors of the commission.